跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 204 条关于
“Telomir-Zn”
全部
204
临床试验
138
药物
41
机构
1
资讯
24
上个月
Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models via Iron-Dependent KDM Inhibition, Preclinical Study Shows
5个月前
Telomir Pharmaceuticals Secures Global Rights to Telomir-1 Through TELI Acquisition, Advances Toward Triple-Negative Breast Cancer Trial
去年
Telomir Pharmaceuticals' Telomir-1 Shows Copper-Binding Potential for Wilson's Disease Treatment
去年
Telomir-1 Outperforms Standard Chemotherapy in Reversing Cancer Gene Silencing
去年
Telomir Pharmaceuticals' Lead Compound Shows Promise in Reversing Cancer Gene Silencing
去年
Telomir-1 Shows Complete Reversal of Oxidative Stress in Breakthrough Preclinical Study
去年
Telomir Pharmaceuticals Develops Novel Silver(II) Antimicrobial to Combat Drug-Resistant Infections
去年
Telomir Pharmaceuticals Secures $3 Million Investment to Advance Novel Age-Reversal Drug for Rare Diseases
11个月前
Telomir-1 Demonstrates Selective Killing of Triple-Negative Breast Cancer Cells Through Iron-Dependent Mechanism
2年前
FDA Lifts Partial Clinical Hold on Azenosertib Trials in Advanced Solid Tumors
第 1 页,共 3 页
上一页
下一页